Singapore vs South Africa: Number of isolates tested for ceftriaxone
Singapore
232
in 2020
South Africa
316
in 2020
Singapore rank
13th
South Africa rank
10th
Number of isolates tested for ceftriaxone over time
- Singapore
- South Africa
How they compare
South Africa currently reports 316 against 232 in Singapore, a difference of 84.
That makes South Africa's figure about 1.4 times Singapore's.
The two have swapped places 3 times across 6 shared years of data; in 2011 it was Singapore ahead.
Singapore ranks 13th and South Africa ranks 10th of 52 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Singapore | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 101.4 | 216.6 | 115.2 | South Africa |
| 2020s | 232 | 316 | 84 | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Singapore or South Africa?
- South Africa, at 316 against 232 in Singapore as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Singapore and South Africa?
- 84, with South Africa ahead.
- How many years of comparable data are there for Singapore and South Africa?
- 6 years are reported by both, from 2011 to 2020.
- How do Singapore and South Africa rank globally for number of isolates tested for ceftriaxone?
- Singapore ranks 13th and South Africa ranks 10th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.